| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
06-05-2009, 09:46 AM
|
#1 | |||
|
||||
|
Magnate
|
California Stem Cell Chief Seeks Trials in Four Years (Update2)
By Rob Waters http://www.bloomberg.com/apps/news?p...d=aQ9ygdVJrhAg June 4 (Bloomberg) -- California’s $3 billion stem-cell funding agency wants to get 10 to 12 new therapies into human testing within four years, said the agency’s president, Alan Trounson. In December, the California Institute of Regenerative Medicine plans to award grants of about $20 million each to 10 or 12 teams, with the goal of starting clinical trials within four years, Trounson said today in an interview. Most or all of the teams will include biotechnology companies, he said. The San Francisco-based institute, established by voters in 2004, is putting greater emphasis on advancing research from laboratory testing to patient trials, said Trounson. After years of stem cell research being conducted largely by academics, companies are deepening their investment in the field, he said. The agency eventually would like to draw in big pharmaceutical companies to help fund the research. Geron’s Okarma Urges Obama to Set Up Stem Cell Panel (Update1) By Rob Waters http://www.bloomberg.com/apps/news?p...d=aRm7cuXNbM3g June 4 (Bloomberg) -- President Barack Obama should appoint a commission on stem cell research to help the therapy fulfill its promise to save lives and reduce medical costs, Geron Corp. Chief Executive Officer Tom Okarma said. Obama’s health advisers ignored Okarma’s idea before the president took office. Okarma proposed the national commission as part of a group from the Biotechnology Industry Organization, a Washington-based industry trade association, he said yesterday in an interview. Okarma is a member of the health section of the association’s board of directors. Researchers At The University Of Tennessee Health Science Center Begin New Study On Parkinson's Disease Medical News Today, Article Date: 04 Jun 2009 - 4:00 PDT http://www.medicalnewstoday.com/articles/152557.php Researchers at the University of Tennessee Health Science Center (UTHSC) are recruiting participants for a national clinical study of medication that could slow the progression of Parkinson's disease. The study, referred to as "QE3," will examine the effectiveness of the research medication Coenzyme Q10 (CoQ). During the study, investigators will administer high doses of CoQ to participants 30 years of age or older with early stage Parkinson's disease to reduce the speed of their physical decline. The research is sponsored by the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health (NIH), and will be conducted by the Parkinson Study Group, an international council of physicians and researchers experienced in caring for Parkinson's patients and studying the di Excellent article for Part D users!! Options exist for Medicare ‘doughnut hole’ Centre Daily Times, By Judith Furfaro, Thursday, Jun. 04, 2009 http://www.centredaily.com/479/v-pri...y/1326141.html Q:Help! I have gotten into the “doughnut hole” with my Medicare Part D Prescription Drug Plan. What can I do to help with my expenses? A: There are several things you might do: •Apply for the Extra Help/Low-Income Subsidy (LIS) if you’re single and your monthly income is below $1,354, (or $1,822 if you’re married and living with your spouse) and your resources are less than $12,510 if you’re single (or $25,010 if you’re married and living with your spouse). Medicare beneficiaries with limited incomes and resources who qualify for the LIS have no coverage gap. Low-Income Subsidy PACE/PACENET NEW ZEALAND: Students Make Film For Parkinson's New Zealand Voxy.co.nz, Thursday, 4 June, 2009 - 14:46 http://www.voxy.co.nz/national/stude...ealand/5/15459 Parkinson's New Zealand was chosen by a group of Massey University Public Relations Students for their class project focusing on creating awareness and exposure for a not-for-profit. The students decided to make a film for Parkinson's New Zealand. Parkinson's New Zealand provides education, information and support for people with Parkinson's, their caregivers, friends and families. Click here: http://www.youtube.com/user/ParkinsonsNewZealand to view the newly completed film. It is also available on http://www.parkinsons.org.nz Music therapy treats diseases and conditions from Parkinson's to autism Daily News, NY, Thursday, June 4th 2009, 4:00 AM, BY Rosemary Black, DAILY NEWS STAFF WRITER http://www.nydailynews.com/lifestyle...to_autism.html Listen up: belting out tunes in the shower may not only be music to your ears, but may also treat a variety of disorders such as Parkinson’s disease, aphasia and dementia. “When neural pathways are damaged for one particular function such as language, musical neural pathways are actually much more complex and much more widespread within the brain,” she told CNN. “Music seems to find re-routed paths and that is why it is such a useful tool in terms of helping people with different kinds of brain damage because it can help to find new pathways in terms of brain functioning.” Protein Behind Development of Parkinson’s can be Treated With Man-made Polymer Med India, Thursday, June 04, 2009 at 4:27:05 PM http://www.medindia.net/news/Protein...er-52422-1.htm Alpha-Synuclein, a protein known to play a role in the development of Parkinson’s disease can be tackled effectively by a using a man-made polymer, called dendrimer, shows nuclear-based research from Australian Nuclear Science and Technology Organisation (ANSTO). The abnormal behaviour of patients can be stopped or even reversed by using dendrimer, also known as a ‘dense star’ polymer. Parkinson's disease linked to pesticides UPI, Published: June 5, 2009 at 1:15 AM http://www.upi.com/Health_News/2009/...2081244178901/ PARIS, June 5 (UPI) -- An epidemiological study involving French farm worker exposure to pesticides found an association with Parkinson's disease, researchers found. Dr. Alexis Elbaz of the French National Institute for Health and Medical Research and University Pierre et Marie Curie said the study involved people with the French health insurance organization for agricultural workers who were frequently exposed to pesticides. Parkinson's Disease Associated With Pesticide Exposure In French Farm Workers http://www.sciencedaily.com/releases...0604124802.htm ScienceDaily (June 4, 2009) — The cause of Parkinson’s disease (PD), the second most frequent neurodegenerative disease after Alzheimer’s disease, is unknown, but in most cases it is believed to involve a combination of environmental risk factors and genetic susceptibility. Laboratory studies in rats have shown that injecting the insecticide rotenone leads to an animal model of PD and several epidemiological studies have shown an association between pesticides and PD, but most have not identified specific pesticides or studied the amount of exposure relating to the association. Harnessing The Brain's Own Ability For Repair Medical News Today, Article Date: 04 Jun 2009 - 4:00 PDT http://www.medicalnewstoday.com/articles/152563.php New findings throw light on how the brain heals itself and may change the way we think about treating chronic neurodegenerative diseases like Parkinson's and Alzheimer's. Neuroscientists at Sydney's Garvan Institute of Medical Research have shown that nerve cells in the brain produce an anti-inflammatory molecule that allows the brain to repair itself. These findings, by Drs Bryce Vissel and Andrea Abdipranoto, are published online today in the international journal Stem Cells. Snoring May Impair Brain Function Medical News Today, Article Date: 04 Jun 2009 - 6:00 PDT http://www.medicalnewstoday.com/articles/152602.php It has been linked to learning impairment, stroke and premature death. Now UNSW research has found that snoring associated with sleep apnoea may impair brain function more than previously thought. Sufferers of obstructive sleep apnoea experience similar changes in brain biochemistry as people who have had a severe stroke or who are dying, the research shows. Seeing More With Rose-Coloured Glasses Medical News Today, Article Date: 05 Jun 2009 - 2:00 PDT http://www.medicalnewstoday.com/articles/152653.php "Good and bad moods literally change the way our visual cortex operates and how we see," says Adam Anderson, a U of T professor of psychology. "Specifically our study shows that when in a positive mood, our visual cortex takes in more information, while negative moods result in tunnel vision. The study appears in the Journal of Neuroscience. Are generic drugs equal to brand name products? Paging Dr. Gupta, June 4, 2009, Posted: 11:14 AM ET http://pagingdrgupta.blogs.cnn.com/2...name-products/ As a new feature of CNNhealth.com, our team of expert doctors will answer readers’ questions. Here’s a question for Dr. Gupta. From Don, New Berlin, New York “I am curious to know the differences between generic and name-brand drugs. What makes the prices so different? Is there a difference in quality?”
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller |
|||
|
 Reply With Quote
|
| "Thanks for this!" says: | olsen (06-05-2009) |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| trade brand dilantin vs. generic | Epilepsy | |||
| Big difference in generic and name brand!!! | Medications & Treatments | |||
| NEWS: Brand-Name Companies Could Face Generic Competition On Biotechnology Drugs | Parkinson's Disease | |||
| SINEMIT generic vs brand name | Parkinson's Disease | |||
News: Generic vs Brand...Rose Coloured Glasses...New Zealand Students PD Film...more
Linear Mode
